down arrow

Glenmark Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
1,370.20
-6.15 (-0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
28.22
28.22
28.22
28.22
28.22
28.22
Share Warrants & Outstandings
Total Reserve
7,819.71
9,445.71
9,058.43
7,036.41
6,042.29
5,576.97
Shareholder's Funds
7,847.93
9,473.92
9,086.65
7,064.63
6,070.51
5,605.18
Minority Interest
-0.38
365.34
351.47
-0.35
-0.39
-0.38
Long-Term Borrowings
157.24
3,997.72
3,300.35
3,888.82
4,426.04
4,145.64
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
157.24
3,997.72
3,300.35
3,888.82
4,426.04
4,145.64
Deferred Tax Assets / Liabilities
-1,049.44
-1,805.40
-1,654.63
-1,505.92
-1,439.26
-1,382.95
Other Long Term Liabilities
692.21
574.709
352.498
420.719
429.269
89.1360000000002
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
-357.23
2,621.45
1,269.61
2,803.62
3,033.01
2,279.94
Current Liabilities
Trade Payables
2,535.93
2,000.43
2,288.66
2,237.77
2,125.84
2,220.75
Other Current Liabilities
1,650.94
2,117.04
810.78
650.31
1,042.34
1,058.97
Short Term Borrowings
990.60
495.58
1,098.61
798.61
442.60
303.02
Short Term Provisions
641.12
492.01
491.38
514.33
515.20
438.35
Total Current Liabilities
5,818.59
5,105.06
4,689.43
4,201.02
4,125.98
4,021.09
Total Liabilities
13,308.90
17,565.76
15,397.17
14,068.91
13,229.10
11,905.84
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
9,026.27
9,820.58
9,725.06
8,304.81
8,269.83
6,527.27
Less: Accumulated Depreciation
5,015.19
4,615.39
4,086.88
3,441.14
3,241.28
2,857.01
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
4,011.09
5,205.19
5,638.18
4,863.67
5,028.56
3,670.25
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
419.32
1,065.82
921.09
1,217.79
1,090.64
1,234.37
Intangible assets under development
242.56
123.81
88.78
163.88
131.25
164.57
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
789.66
44.57
49.62
24.62
24.59
29.66
Long Term Loans & Advances
211.70
180.80
161.38
146.29
123.97
94.36
Other Non Current Assets
7.42
3.46
6.70
27.89
26.49
15.80
Total Non-Current Assets
5,880.82
6,840.24
7,114.82
6,709.33
6,425.49
5,209.02
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
2,513.05
2,373.62
2,499.83
2,276.83
2,135.62
2,252.07
Sundry Debtors
1,858.41
3,665.17
3,101.14
2,572.05
2,408.96
2,194.59
Cash and Bank
1,659.46
1,160.30
1,411.52
1,139.16
1,111.24
937.76
Other Current Assets
178.21
2,618.50
297.46
324.60
237.15
319.63
Short Term Loans and Advances
1,218.95
907.93
972.41
1,046.93
910.64
992.76
Total Current Assets
7,428.08
10,725.53
8,282.35
7,359.58
6,803.62
6,696.82
Net Current Assets (Including Current Investments)
1,609.49
5,620.47
3,592.92
3,158.56
2,677.63
2,675.73
Total Current Assets Excluding Current Investments
7,428.08
10,725.53
8,282.35
7,359.58
6,803.62
6,696.82
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
13,308.90
17,565.76
15,397.17
14,068.91
13,229.10
11,905.84
Contingent Liabilities
1,063.30
336.69
361.31
384.20
271.21
73.51
Total Debt
833.36
4,202.14
2,941.74
4,687.43
4,102.55
3,304.89
Book Value per share (adjusted)
0
335.75
322.03
250.37
215.14
198.65
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is -77.22% vs 18.46% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is 20.45% vs 63.04% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is -29.35% vs -4.39% in Mar 2023

stock-summary

Investments

YoY Growth in year ended Mar 2024 is 1,671.73% vs -10.18% in Mar 2023

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is -30.74% vs 29.50% in Mar 2023

Compare Balance Sheet Results of Glenmark Pharma
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.22
40.06
-11.84
-29.56%
Share Warrants & Outstandings
Total Reserve
7,819.71
9,299.78
-1,480.07
-15.92%
Shareholder's Funds
7,847.93
9,363.09
-1,515.16
-16.18%
Minority Interest
-0.38
212.70
-213.08
-100.18%
Long-Term Borrowings
157.24
24.87
132.37
532.25%
Secured Loans
0.00
24.87
-24.87
-100.00%
Unsecured Loans
157.24
0.00
157.24
0.00%
Deferred Tax Assets / Liabilities
-1,049.44
8.67
-1,058.11
-12,204.27%
Other Long Term Liabilities
692.21
30.68
661.53
2,156.23%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
123.12
-123.12
-100.00%
Total Non-Current Liabilities
-357.23
187.34
-544.57
-290.69%
Current Liabilities
Trade Payables
2,535.93
1,102.99
1,432.94
129.91%
Other Current Liabilities
1,650.94
456.26
1,194.68
261.84%
Short Term Borrowings
990.60
171.17
819.43
478.72%
Short Term Provisions
641.12
389.31
251.81
64.68%
Total Current Liabilities
5,818.59
2,119.73
3,698.86
174.50%
Total Liabilities
13,308.90
11,882.86
1,426.04
12.00%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9,026.27
5,775.71
3,250.56
56.28%
Less: Accumulated Depreciation
5,015.19
1,354.82
3,660.37
270.17%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
4,011.09
4,420.89
-409.80
-9.27%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
419.32
207.09
212.23
102.48%
Intangible assets under development
242.56
74.70
167.86
224.71%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
789.66
315.12
474.54
150.59%
Long Term Loans & Advances
211.70
163.97
47.73
29.11%
Other Non Current Assets
7.42
13.79
-6.37
-46.19%
Total Non-Current Assets
5,880.82
5,314.63
566.19
10.65%
Current Assets Loans & Advances
Current Investments
0.00
2,258.11
-2,258.11
-100.00%
Inventories
2,513.05
1,553.46
959.59
61.77%
Sundry Debtors
1,858.41
848.28
1,010.13
119.08%
Cash and Bank
1,659.46
1,197.97
461.49
38.52%
Other Current Assets
178.21
106.80
71.41
66.86%
Short Term Loans and Advances
1,218.95
610.77
608.18
99.58%
Total Current Assets
7,428.08
6,568.23
859.85
13.09%
Net Current Assets (Including Current Investments)
1,609.49
4,448.50
-2,839.01
-63.82%
Total Current Assets Excluding Current Investments
7,428.08
4,310.11
3,117.97
72.34%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
13,308.90
11,882.86
1,426.04
12.00%
Contingent Liabilities
1,063.30
116.23
947.07
814.82%
Total Debt
833.36
196.04
637.32
325.10%
Book Value per share (adjusted)
0.00
233.73
-233.73
-100.00%
Annual - Borrowings
Borrowings 990.60 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -77.22% vs 18.46% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 692.21 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 20.45% vs 63.04% in Mar 2023

Annual - Fixed Assets
Fixed Assets 4,430.41 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -29.35% vs -4.39% in Mar 2023

Annual - Investments
Investments 789.66 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1,671.73% vs -10.18% in Mar 2023

Annual - Current Assets
Current Assets 7,428.08 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -30.74% vs 29.50% in Mar 2023